Article
Author(s):
Retinal detachment risk after B1KPro
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Sexual harassment remains high in ophthalmology
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Efficacy and safety findings for lenadogene nolparvovec (Lumevoq) from REFLECT Phase III trial
Seonix Bio launches SightScore testing service for primary open-angle glaucoma
